Today's Date
Promoting Tolerance to Common Allergens in High-Risk Children: Global Prevention of Asthma in Children
(
GPAC
)
ITN Protocol #:
ITN025AD
Branded Name:
GPAC
ClinicalTrials.Gov ID:
NCT00346398Treatment Protocol #:
Immuno-prophylaxis
Therapeutic Area:
Allergy & Asthma
Current Status:
Complete
Summary:
A Phase II Multicenter, Controlled, Double-Blind Study Using Immunoprophylaxis in the Primary Prevention of Allergic Disease
Clinical Operations Manager
Rho Data Manager
Study Personnel:
